82 FR 12821 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 82, Issue 43 (March 7, 2017)

[Federal Register Volume 82, Number 43 (Tuesday, March 7, 2017)]
[Notices]
[Page 12821]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-04354]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcement (FOA) 
DP15-0020301SUPP17, Supplement to Enhance Laboratory and Statistical 
Support of the Population Registry of Diabetes in Youth.

TIME AND DATE:  11:00 a.m.-2:00 p.m., EDT, March 29, 2017 (Closed).

PLACE: Teleconference.

STATUS: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.

MATTERS FOR DISCUSSION: The meeting will include the initial review, 
discussion, and evaluation of applications received in response to 
``Supplement to Enhance Laboratory and Statistical Support of the 
Population Registry of Diabetes in Youth'', FOA DP15-0020301SUPP17.

CONTACT PERSON FOR MORE INFORMATION: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected] delegated the 
authority to sign Federal Register notices pertaining to announcements 
of meetings and other committee management activities, for both the 
Centers for Disease Control and Prevention and the Agency for Toxic 
Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2017-04354 Filed 3-6-17; 8:45 am]
 BILLING CODE 4163-18-P